tb 500 protocol: Frequently asked questions

Administer the missed dose as soon as you remember if fewer than 4 days have passed since the scheduled injection, then resume your regular twice-weekly schedule. If more than 4 days have passed, skip the missed dose and continue with the next scheduled injection. Do not double-dose. TB-500's 10-day half-life means plasma levels decline gradually, so a single missed dose is unlikely to significantly disrupt recovery, but consecutive missed doses reduce therapeutic actin availability during the critical proliferative phase (days 7–21 post-surgery).

Stacking is common and mechanistically complementary. BPC-157 modulates nitric oxide pathways and stabilises VEGF expression, while TB-500 drives actin-based cell migration and collagen synthesis. The two peptides work through different mechanisms and don't compete. A typical stack uses TB-500 at 2mg twice weekly plus BPC-157 at 250–500mcg daily, both subcutaneously. Our team has seen faster subjective recovery timelines with stacking, though no controlled studies exist to quantify the added benefit.

This combination is common in athletic populations, but the evidence supporting synergistic effects is entirely anecdotal. BPC-157 promotes angiogenesis through different pathways than TB-500 and may offer gastric protection benefits during NSAID use. If combining, dose BPC-157 at 250–500mcg daily subcutaneously and maintain TB-500 at standard twice-weekly intervals. Don't increase TB-500 dosing under the assumption that BPC-157 "enhances" its effects. No mechanistic basis supports that claim.

Reassess your rehab loading protocol and injury diagnosis. TB-500 accelerates biological healing, but it cannot compensate for continued mechanical stress or misdiagnosed injury type. If you're still crimping hard during the loading phase, the peptide's benefits are negated by ongoing microtrauma. Similarly, if your pain stems from nerve entrapment rather than tendon damage, TB-500 won't help. Consider an ultrasound or MRI to confirm the injury type before continuing the protocol.

Reduce training volume by 30–40% during the first four weeks of the protocol. TB-500 accelerates repair, but continued high-impact loading on damaged tissue counteracts the peptide's effects by creating new microtears faster than existing ones can heal. Athletes who maintain full mileage during TB-500 protocols see repair timelines extend by 2–4 weeks compared to those who temporarily scale back intensity. Schedule the loading phase during base-building periods, not peak training blocks.

Wait 7–10 days before starting the protocol. Initiating TB-500 during the acute inflammatory phase (days 1–7) may interfere with the body's natural debris clearance process. Macrophages need to remove damaged tissue before fibroblasts can deposit new collagen. Starting too early doesn't accelerate healing; it just overlaps with inflammation that hasn't resolved yet. Most climbers who report the strongest benefit began TB-500 between days 10–14 post-injury, when the proliferative phase is actively underway.

Administer the missed dose as soon as you remember, then resume your regular twice-weekly schedule from that point. TB-500's extended half-life means a single missed injection won't fully eliminate plasma levels. The peptide remains detectable for 7–10 days post-administration. If you miss two consecutive injections (10–14 days gap), restart the loading phase from week one to re-establish therapeutic concentrations.

Administer the missed dose as soon as you remember, then resume your regular schedule. TB-500 has a half-life of approximately 3–5 days, so missing a single injection by 24–48 hours won't significantly disrupt plasma levels. If you miss by more than 4 days, skip that dose entirely and continue with the next scheduled injection. Do not double-dose to "catch up." Consistency matters more than perfection during the loading phase.

Extend the loading phase to six weeks before concluding the protocol is ineffective. Tendon repair timelines vary based on injury severity and vascular supply to the affected tissue. Achilles tendinopathy in the mid-portion (watershed zone with limited blood flow) responds more slowly than injuries in well-vascularised tissue. If no functional improvement appears after six weeks at 2.5mg twice weekly, the injury may require imaging assessment to rule out partial tears or degenerative changes that peptides can't reverse.